Skip to content

Clinical trials

Phase 1/2 trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Country / region: Serbia Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20071
20082
20092
20102
20122
20152
20172
20181
20191
20201
20231
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting6
Unknown status3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
4TEEN4 Pharmaceuticals GmbH1
Ablynx, a Sanofi company1
AstraZeneca1
Climb Bio, Inc.1
Egetis Therapeutics1
Forever Young d.o.o.1
G1 Therapeutics, Inc.1
Gemin X1
Grifols Therapeutics LLC1
Immatics Biotechnologies GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms2
Colorectal Neoplasms2
Small Cell Lung Carcinoma2
Adenocarcinoma1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Transitional Cell1
Cystic Fibrosis1
Fabry Disease1
Fatigue1
Febrile Neutropenia1

Trials

Showing 76 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.